A 48-year-old woman with a 10-year history of essential hypertension is found to have a blood pressure of 165/105 mmHg on routine clinic visit. She is currently on amlodipine monotherapy. The physician decides to add an ACE inhibitor. Which of the following best explains why the addition of an ACE inhibitor will reduce blood pressure through a mechanism distinct from calcium channel blockade?

Explanation

## Complementary Mechanisms: ACE Inhibitors vs. Calcium Channel Blockers This question tests understanding of **dual-pathway blood pressure regulation** and why combination therapy is more effective than monotherapy in hypertension. ### Distinct Mechanisms of BP Reduction **Key Point:** ACE inhibitors and calcium channel blockers work on **orthogonal pathways**—one addresses the renin-angiotensin-aldosterone system (RAAS) and the other addresses vascular smooth muscle contractility. This is why they are synergistic. ### Mechanism Comparison | Mechanism | Amlodipine (CCB) | ACE Inhibitor | |-----------|------------------|---------------| | **Primary target** | L-type Ca²⁺ channels in VSM | Angiotensin II formation | | **Direct effect** | Vasodilation via reduced [Ca²⁺]ᵢ | ↓ Vasoconstriction (AT1 blockade) | | **Secondary effect** | Reflex sympathetic activation | ↓ Aldosterone → ↓ Na⁺ retention | | **Volume effect** | Minimal | ↓ Intravascular volume | | **Renal protection** | Modest | Marked (efferent arteriole dilation) | ### Why ACE Inhibitors Add Value to CCB Monotherapy 1. **Angiotensin II suppression** → blocks AT1-mediated vasoconstriction (amlodipine does NOT block this) 2. **Aldosterone inhibition** → reduces sodium reabsorption and intravascular volume expansion (amlodipine does NOT address volume) 3. **Efferent arteriole dilation** → reduces glomerular hyperfiltration and protects the kidney 4. **Counteracts reflex sympathetic activation** → amlodipine alone can trigger reflex tachycardia and SNS activation; ACE inhibitor blunts this **High-Yield:** The combination of a CCB + ACE inhibitor is **synergistic** because: - CCB reduces vascular tone acutely - ACE inhibitor reduces volume and blocks the RAAS-mediated counter-regulation - Together they address both **resistance** and **volume** components of hypertension **Clinical Pearl:** Patients on amlodipine monotherapy who develop reflex tachycardia or inadequate BP control benefit from ACE inhibitor addition because the ACE inhibitor dampens the sympathetic counter-response and addresses the RAAS, which is often activated in response to CCB-induced vasodilation. **Mnemonic — RAAS Blockade by ACE-I:** **R**enin suppressed → **A**ngiotensin II ↓ → **A**ldosterone ↓ → **S**odium retention ↓ = Volume ↓ = BP ↓ [cite:KD Tripathi 8e Ch 21]